FDA Approves Second CAR T-Cell Therapy FDA Approves Second CAR T-Cell Therapy

The second therapy of this innovative immunotherapy has received FDA approval to treat patients with relapsed/refractory aggressive B-cell NHL.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news